Muscle
The Muscle capability encompasses basic, translational, and clinical approaches to maintain and restore skeletal muscle structure and function. Focus areas include injury mechanisms (blast, laceration, ischemia, disuse), diagnostics and biomarkers, regenerative therapies, biomaterials, infection control, rehabilitation technologies, and remote monitoring for austere and prolonged-field-care environments.
Technical Challenges
Complex polytrauma and blast-related muscle loss with concomitant nerve, vascular, and bone injury complicating repair.
Rapid onset atrophy and fibrosis after immobilization or delayed evacuation limiting functional recovery.
Biofilm formation, soft-tissue infection, and antimicrobial resistance impeding grafts, implants, and regenerative therapies.
Limited diagnostics and validated biomarkers for real-time assessment of muscle viability and regenerative potential in austere settings.
Emerging Opportunities
Portable, field-deployable diagnostics to quantify muscle injury severity, ischemia, perfusion, and infection risk.
Scalable, off-the-shelf regenerative therapies (scaffolds, cell-derived products) that integrate with contaminated wounds and restore volumetric muscle loss.
Interventions that prevent fibrosis and promote neuromuscular junction reinnervation after delayed or prolonged care.
Validated outcome metrics and clinician decision-support tools optimized for prolonged field care and transition to rehabilitation.
Current and Emerging Technologies in Muscle
Tissue engineering & scaffolds
Biocompatible scaffolds and extracellular-matrix mimetics for volumetric muscle loss (VML) that support cell infiltration, vascularization, and functional contractile tissue formation.
Cell and gene therapies
Mesenchymal, satellite, and induced pluripotent stem cell approaches, plus gene editing and RNA therapeutics to enhance regeneration, reduce fibrosis, and restore neuromuscular connectivity.
Biomaterials, antimicrobials & anti-fibrotics
Advanced biomaterials with integrated antimicrobial agents, controlled-release anti-fibrotic compounds, and coatings designed to resist biofilms in contaminated battlefield wounds.
Diagnostics & biomarkers
Molecular and imaging biomarkers (circulating miRNA, proteomics, point-of-care ultrasound, perfusion imaging) to stratify injury, predict recovery, and guide timing of reconstruction.
Wearables, remote monitoring & telemedicine
Sensor arrays and wearable EMG/accelerometry for continuous assessment of muscle activity, fatigue, and rehabilitation progress during prolonged field care and distributed operations.
Rehabilitation robotics & neuromodulation
Portable exoskeletons, functional electrical stimulation, and closed-loop neuromodulation to accelerate strength recovery and retrain motor patterns after nerve or muscle injury.
Importance to Military Medicine
Combat casualty care and rapid stabilization
Effective muscle-sparing strategies and reconstructive options reduce morbidity from blast and soft-tissue injuries, improving survival and limb salvage.
Prolonged and austere care resilience
Interventions that limit atrophy, infection, and fibrosis enable functional maintenance during delayed evacuation or extended field treatment.
Force readiness and return-to-duty
Restoring neuromuscular function shortens rehabilitation timelines and preserves operational capability across deployments.
Reconstruction and long-term recovery
Regenerative solutions reduce chronic disability from volumetric muscle loss and improve quality of life for injured Service members and veterans.
Alignment with the MTEC Mission
Directly supports DoD priorities: accelerate translation of regenerative and diagnostic technologies for battlefield injuries and prolonged care.
Enables force health protection by addressing infection control, antimicrobial resistance, and wound management in tactical environments.
Advances dual-use solutions that benefit civilian trauma care, orthopedics, and rehabilitation while expediting Warfighter impact.
Dual-Use (Military + Civilian) Applications
Acute battlefield interventions and surgical reconstruction for VML and complex extremity trauma.
Prolonged field care solutions: portable diagnostics, infection-resistant implants, and temporizing regenerative materials.
Rehabilitation and performance optimization: wearables, neuromodulation, and robotics for accelerated return-to-duty.
Explore MTEC Members with Muscle Capabilities
MTEC members combine academic muscle biology, industry-scale manufacturing of biomaterials and cell products, and military clinical experience to de-risk translational pathways.
Consortium capabilities accelerate iterative testing in realistic operational contexts, integrate regulatory and commercialization expertise, and enable multi-partner trials.
Explore our member profiles to identify collaborators with strengths in regenerative medicine, point-of-care diagnostics, biofilm-resistant biomaterials, rehabilitation engineering, and clinical trial execution.
127 Members with Muscle capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.

Stream Biomedical, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class targeted therapeutics for acute neurotrauma and chronic neurodegenerative diseases. The company is dedicated to revolutionizing cerebrovascular repair and developing novel solutions for neurotrauma and neurodegeneration, including conditions such as stroke, traumatic brain injury, and Alzheimer's disease.

FiteBac Technology/FiteBac Pharma's K21 uniquely targets the underlying disease state, given that most diseases involve microbial-associated inflammation and mitochondrial dysfunction. FiteBac Technology innovations stem from the work of numerous international academic research scientists. FiteBac Pharma K21 is the blockbuster antimicrobial small molecule designed to modulate biological, immunological, and metabolic systems for treating a wide range of infectious and inflammatory diseases. This patented drug substance has demonstrated the ability to safely eliminate bacterial, fungal, and viral infections, enhance innate immunity, induce mitophagy while improving mitochondrial and cellular metabolism, accelerate wound healing, and even promote the development of zebrafish and chickens, leading to increased adult mass. Rigorous research from Dr. Bhupesh Prusty's laboratory and Dr Christopher Rongo's laboratory is focused on various aspects of mitochondrial remodeling and reprograming, as well as mitochondrial-to-nuclear signaling with K21.

MTF Biologics is a leading non-profit organization dedicated to saving and healing lives by honoring the gift of tissue donation. They process tissue grafts from human donors for a wide range of clinical applications, positively impacting lives globally. MTF Biologics integrates service, science, and advocacy to improve healthcare and wellbeing, while also supporting research and innovation in tissue transplantation.

Maverick Labs is a U.S.-based biotechnology and materials science company specializing in advanced protein design, synthetic biology, and microbial engineering. The company operates through three tightly integrated subsidiaries—Maverick Metals, Maverick Energy, and the Maverick Bio-Gene Therapy Translational Unit—each of which applies a shared technological foundation to tackle critical challenges across national defense, energy independence, and strategic material access. Together, they develop scalable, field-ready solutions that reinforce the United States’ industrial resilience and military readiness through biotechnology-driven innovation.
Massachusetts General Hospital (Mass General) is a world-renowned academic medical center and the original and largest teaching hospital of Harvard Medical School. Mass General is recognized for its commitment to high-quality patient care, innovative research, and comprehensive educational opportunities. The hospital operates the largest hospital-based research program in the United States, fostering collaboration among leading clinicians and scientists to bridge innovation science with state-of-the-art clinical medicine. Mass General for Children (MGfC) is a leader in pediatric care, offering more than 50 medical specialties and 15 surgical services, and is home to the only proton beam facility in New England. The hospital is dedicated to serving local and global communities, training the next generation of healthcare professionals, and advancing medical knowledge through groundbreaking research, multidisciplinary care, and a strong commitment to family-centered and equitable healthcare.

The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.

SolasCure is dedicated to transforming chronic wound care through innovative therapeutic solutions. The company is at the forefront of developing Aurase Wound Gel, a breakthrough enzymatic debrider designed to return chronic wounds to healing. SolasCure aims to shift the paradigm in wound care by providing high-impact, safe, and effective treatments that address the underlying causes of wounds rather than just managing symptoms. With a strong focus on research and development, SolasCure is committed to improving the health and wellbeing of patients worldwide.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.

UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.

The University of Queensland (UQ) is one of Australia's leading research and teaching institutions, dedicated to transforming lives through education and research. UQ aims to create a better future by equipping students with the skills and knowledge necessary for their chosen careers, while also addressing some of the world's most complex challenges through innovative research.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.
Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI